BioSpace News Archive

EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) (“EvokAI” or the “Company”), a leading MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the healthcare sector, is pleased to announce that its latest technology “MDM Flex Sensor” has received the CE Mark approval, a significant milestone that paves the way for further advancements in the field of movement disorder monitoring.

Nextech, a complete healthcare technology solution for specialty providers, is proud to announce its significant growth in market share over the past year, with the addition of more than 250 ophthalmology practices and 1,000 eye care providers to its network.

Allyx Therapeutics presented Phase 1a single ascending dose study results at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) meeting in Boston on October 27, 2023.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that data from its LIVMARLI and volixibat programs will be presented at The Liver Meeting.

OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $4 million to provide patient monitoring solutions and related accessories to a U.S. based hospital.

AnHeart Therapeutics today announced it has entered into an exclusive license agreement with Nippon Kayaku Co., Ltd (“Nippon Kayaku”) to market and distribute AnHeart’s lead investigational therapy, taletrectinib, in Japan.

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that Stephen Mahoney has been appointed the company’s President and Chief Executive Officer, and a member of the Board of Directors, effective immediately.

Zivo Bioscience, Inc. announces the initiation of a 42-day study to further validate the efficacy of its novel immune-modulating treatment for coccidiosis in broiler chickens.

Alpenglow Biosciences, Inc. is thrilled to announce the sponsorship of an engaging dinner lecture on immune exclusion during the Society for Immunotherapy of Cancer conference taking place November 1 - 5, 2023.

AIM ImmunoTech Inc. today announced that an abstract from the Magee-Womens Research Institute at the University of Pittsburgh School of Medicine (“UPMC”) has been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting being held November 1 – 5, 2023 in San Diego, CA and virtually.